Internal Medicine, Hematology & Oncology · West Hills, CA
NPI
1619933132
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7325 Medical Center Dr Ste 301
West Hills, CA, 91307
Phone (818) 570-2134
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
79,034 services
Medicare patients, 2024
401
Average age 75
Drug cost, 2024
$12.3M
1,835 prescriptions
Company payments, 2025
$2,451
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Benjamin was code J1439 (injection, ferric carboxymaltose, 1 mg), 22,750 times for 16 patients. In total Michael S Benjamin billed 79,034 services in 90 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 22,750 | 16 | $0.88 | $20K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 6,800 | 15 | $6.49 | $44K |
| J0897 Injection, denosumab, 1 mg | Office | 2,821 | 22 | $20.26 | $57K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,655 | 33 | $0.09 | $238 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,666 | 31 | $0.26 | $435 |
| 99213 Office E&M - Established | Office | 1,338 | 285 | $73.68 | $99K |
| 96372 Injection Administration | Office | 754 | 107 | $11.87 | $8,948 |
| 96367 Intravenous Infusion, Hydration | Office | 520 | 39 | $25.36 | $13K |
| 96366 Intravenous Infusion, Hydration | Office | 502 | 61 | $17.66 | $8,864 |
| 96365 Intravenous Infusion, Hydration | Office | 260 | 58 | $55.10 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 249 | 55 | $97.09 | $24K |
| 96375 Injection Administration | Office | 232 | 41 | $13.61 | $3,158 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 221 | 38 | $0.65 | $144 |
| 96413 Chemotherapy Administration | Office | 197 | 26 | $117.06 | $23K |
| 99214 Office E&M - Established | Office | 164 | 108 | $96.69 | $16K |
By year: 2022 $1.7M for 88,518 services; 2023 $2.5M for 103,503 services; 2024 $2.1M for 79,034 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Benjamin prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 502 prescriptions and refills. In total Michael S Benjamin wrote 1,835 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 502 | 504 | 90 | $2.7M |
| Xtandi Enzalutamide | 242 | 242 | 41 | $3.2M |
| Neulasta Pegfilgrastim | 126 | 126 | 18 | $934K |
| Xgeva Denosumab | 94 | 96 | 12 | $278K |
| Lupron Depot Leuprolide Acetate | 72 | 208 | 33 | $377K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 63 | 63 | Under 11 | $403K |
| Calquence Acalabrutinib Maleate | 41 | 41 | Under 11 | $625K |
| Imbruvica Ibrutinib | 40 | 40 | Under 11 | $627K |
| Anastrozole Generic | 36 | 86 | 14 | $491 |
| Fulvestrant Generic | 35 | 35 | Under 11 | $14K |
| Imatinib Mesylate Generic | 30 | 30 | Under 11 | $27K |
| Ondansetron Hcl Generic | 25 | 25 | Under 11 | $298 |
| Eliquis Apixaban | 23 | 29 | Under 11 | $17K |
| Kisqali Ribociclib Succinate | 22 | 22 | Under 11 | $326K |
| Hydroxyurea Generic | 21 | 54 | Under 11 | $345 |
Brand drugs: 1,539 claims; generic drugs: 296 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Benjamin $2,451 ($2,451 in general payments such as food, travel and fees) from 30 companies. The largest payer was Novartis Pharmaceuticals Corporation with $343.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 14 | $343 |
| Pfizer Inc. PFE | 9 | $217 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $195 |
| Genentech USA, Inc. ROG.SW | 7 | $178 |
| Janssen Biotech, Inc. JNJ | 7 | $173 |
| Merck Sharp & Dohme LLC MRK | 5 | $146 |
| Incyte Corporation INCY | 6 | $143 |
| Celgene Corporation BMY | 7 | $141 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $107 |
| Gilead Sciences, Inc. GILD | 4 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.